Beam Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Beam Therapeutics

27/02/2024 12:11

* Beam Therapeutics Inc  BEAM.OQ  reported quarterly
adjusted
earnings of $1.73​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -54 cents.  The mean expectation of
fifteen analysts for the quarter was for a loss of $1.01 per
share. Wall Street expected results to range from $-1.46
to $1.21 per share.
    * Revenue rose 1,478% to $316.19 million from a year ago;
analysts
expected $18.67 million. 
    * Beam Therapeutics Inc's reported EPS for the quarter was
$1.73​.
    * The company reported quarterly net income of $142.8
million.
    * Beam Therapeutics Inc shares had risen by 31.5% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 5.5%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 7
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Beam
Therapeutics
Inc is $41.50 

This summary was machine generated from LSEG data February 27 at
12:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.01          1.73           Beat
 Sep. 30 2023      -1.36          -1.22          Beat
 Jun. 30 2023      -1.42          -1.08          Beat
 Mar. 31 2023      -1.34          -1.33          Beat